Pub Date : 2025-12-01DOI: 10.1016/j.nantod.2025.102944
Shasha Zheng , Ruiqi Huang , Xugang Zhuang , Qian Zhu , Qingyue Cui , Hong Cheng , Wenyu Liang , Chenyu Du , Jing Li , Bin Zhang , Xin Gao , Yusong Wang , Pan Feng , Lei Tian , Yangnan Hu , Zuhong He , Rongrong Zhu , Renjie Chai
Spinal cord injury (SCI) is a traumatic condition of the nervous system that leads to severe disability. Its poor prognosis is largely attributed to uncontrolled inflammation and the intrinsically limited regenerative capacity of the spinal cord, which together severely restrict functional recovery. Hydrogel-based scaffolds represent a prospective strategy for SCI repair, offering structural support and a conducive microenvironment for regeneration. Here, we developed a gelatin methacrylate (GM) hydrogel scaffold incorporating MgFe-layered double hydroxide (LDH) nanoparticles functionalized with brain-derived neurotrophic factor (BDNF). This multifunctional GM-BDNF-LDH scaffold enables sustained release of BDNF, which promotes neuronal survival and regeneration, while LDH contributes additional therapeutic benefits through immunomodulation and neurogenic support. In both in vivo and in vitro experiments, LDH promoted the differentiation of neural stem cells (NSCs) while suppressing the expression of M1 markers and promoting the expression of M2 markers in microglia. Furthermore, the functional scaffold significantly improved motor function restoration, inflammation suppression, and neural differentiation in rats. Together, these results demonstrate that the LDH-functionalized scaffold we proposed can simultaneously modulate the immune microenvironment and promote neuronal regeneration, offering a potential treatment strategy for SCI recovery.
{"title":"MgFe-LDH-doped GelMA hydrogel scaffold repaired spinal cord injury via immunoregulation and enhancement of neuronal differentiation","authors":"Shasha Zheng , Ruiqi Huang , Xugang Zhuang , Qian Zhu , Qingyue Cui , Hong Cheng , Wenyu Liang , Chenyu Du , Jing Li , Bin Zhang , Xin Gao , Yusong Wang , Pan Feng , Lei Tian , Yangnan Hu , Zuhong He , Rongrong Zhu , Renjie Chai","doi":"10.1016/j.nantod.2025.102944","DOIUrl":"10.1016/j.nantod.2025.102944","url":null,"abstract":"<div><div>Spinal cord injury (SCI) is a traumatic condition of the nervous system that leads to severe disability. Its poor prognosis is largely attributed to uncontrolled inflammation and the intrinsically limited regenerative capacity of the spinal cord, which together severely restrict functional recovery. Hydrogel-based scaffolds represent a prospective strategy for SCI repair, offering structural support and a conducive microenvironment for regeneration. Here, we developed a gelatin methacrylate (GM) hydrogel scaffold incorporating MgFe-layered double hydroxide (LDH) nanoparticles functionalized with brain-derived neurotrophic factor (BDNF). This multifunctional GM-BDNF-LDH scaffold enables sustained release of BDNF, which promotes neuronal survival and regeneration, while LDH contributes additional therapeutic benefits through immunomodulation and neurogenic support. In both <em>in vivo</em> and <em>in vitro</em> experiments, LDH promoted the differentiation of neural stem cells (NSCs) while suppressing the expression of M1 markers and promoting the expression of M2 markers in microglia. Furthermore, the functional scaffold significantly improved motor function restoration, inflammation suppression, and neural differentiation in rats. Together, these results demonstrate that the LDH-functionalized scaffold we proposed can simultaneously modulate the immune microenvironment and promote neuronal regeneration, offering a potential treatment strategy for SCI recovery.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102944"},"PeriodicalIF":10.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145682132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-09DOI: 10.1016/j.nantod.2025.102865
Yushuang Wei, Xiangyang Li, Yao Gong, Yue-Xuan Li, Jibin Guan, Bing Yuan, Yue Chen, Hong-Bo Pang
Nanomaterials often need to interact with proteins on the plasma membrane to get cross and access their intracellular targets. Therefore, to fully understand the cell entry mechanism, it is of vital importance to gain a comprehensive insight into the proteome at the interface when nanomaterials encounter the cells. Here, we reported a peroxidase-based proximity labeling method to survey the proteome at the nanoparticle (NP)-cell interface. Horseradish peroxidase (HRP) was conjugated to a variety of NPs and other ligand types while still being able to biotinylate the proteins surrounding NP (or ligand)-receptor complexes. Using two NP-based tracers for macropinocytosis (MP), which is highly relevant to NP internalization, we performed a proteomic survey and revealed the interface proteome difference between traditional and receptor-dependent MP. Moreover, our survey found that E-cadherin (CDH1), while not serving as the primary receptor, is present at the NP-cell interface and is functionally important for the cellular uptake of a wide variety of NPs. Overall, by integrating nanotechnology with proximity labeling, our study provides an approach to map the proteome of NP-cell interface for investigating the molecular mechanism of NP and macromolecule internalization into cells.
{"title":"Peroxidase-catalyzed proximity labeling to survey the proteome of nanomaterial-cell interface during macropinocytosis-mediated internalization.","authors":"Yushuang Wei, Xiangyang Li, Yao Gong, Yue-Xuan Li, Jibin Guan, Bing Yuan, Yue Chen, Hong-Bo Pang","doi":"10.1016/j.nantod.2025.102865","DOIUrl":"10.1016/j.nantod.2025.102865","url":null,"abstract":"<p><p>Nanomaterials often need to interact with proteins on the plasma membrane to get cross and access their intracellular targets. Therefore, to fully understand the cell entry mechanism, it is of vital importance to gain a comprehensive insight into the proteome at the interface when nanomaterials encounter the cells. Here, we reported a peroxidase-based proximity labeling method to survey the proteome at the nanoparticle (NP)-cell interface. Horseradish peroxidase (HRP) was conjugated to a variety of NPs and other ligand types while still being able to biotinylate the proteins surrounding NP (or ligand)-receptor complexes. Using two NP-based tracers for macropinocytosis (MP), which is highly relevant to NP internalization, we performed a proteomic survey and revealed the interface proteome difference between traditional and receptor-dependent MP. Moreover, our survey found that E-cadherin (CDH1), while not serving as the primary receptor, is present at the NP-cell interface and is functionally important for the cellular uptake of a wide variety of NPs. Overall, by integrating nanotechnology with proximity labeling, our study provides an approach to map the proteome of NP-cell interface for investigating the molecular mechanism of NP and macromolecule internalization into cells.</p>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"65 ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12410780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145013639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/S1748-0132(25)00313-5
{"title":"Inside Back Cover - Graphical abstract TOC/TOC in double column continued from OBC if required, otherwise blank page","authors":"","doi":"10.1016/S1748-0132(25)00313-5","DOIUrl":"10.1016/S1748-0132(25)00313-5","url":null,"abstract":"","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102941"},"PeriodicalIF":10.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/S1748-0132(25)00314-7
{"title":"Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information","authors":"","doi":"10.1016/S1748-0132(25)00314-7","DOIUrl":"10.1016/S1748-0132(25)00314-7","url":null,"abstract":"","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102942"},"PeriodicalIF":10.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.nantod.2025.102945
Ke Ma , Ting Liu , Wen-Bo Huan, Ke-Zheng Chen, Sheng-Lin Qiao
Targeted Protein Degradation (TPD) emerges as a novel therapeutic strategy that selectively eliminates disease-causing proteins by harnessing endogenous degradation systems, thereby overcoming the limitations of traditional drugs in addressing “undruggable” targets. This review outlines the core molecular mechanisms and primary technical platforms of TPD, including PROTACs, molecular glues (MGs), antibody-degradation conjugates, and emerging autophagy-related strategies (LYTACs, AUTACs, ATTECs, etc.). It systematically summarizes molecular engineering advances such as linker optimization, expansion of E3 ligase resources, and environmentally responsive and multi-modular designs. Furthermore, clinical and translational research cases demonstrate TPD's application potential across oncology, neurodegenerative diseases, cardiovascular disorders, and infectious diseases. Addressing challenges such as suboptimal pharmacokinetics, delivery limitations, potential off-target effects, and industrialization hurdles, we identify critical scientific questions requiring resolution and highlight emerging directions including AI-enabled design, nanomaterial delivery, and interdisciplinary integration. Overall, TPD is propelling drug development from “functional inhibition” toward “protein clearance,” injecting new vitality into precision medicine. This paper aims to provide a systematic reference for subsequent research and clinical translation.
靶向蛋白降解(Targeted Protein Degradation, TPD)作为一种新的治疗策略出现,它通过利用内源性降解系统选择性地消除致病蛋白,从而克服了传统药物在解决“不可药物”靶标方面的局限性。本文综述了TPD的核心分子机制和主要技术平台,包括PROTACs、分子胶(MGs)、抗体降解偶联物以及新兴的自噬相关策略(lytac、autac、attec等)。系统总结了分子工程方面的研究进展,如连接子优化、E3连接酶资源拓展、环境响应和多模块化设计等。此外,临床和转化研究案例证明了TPD在肿瘤、神经退行性疾病、心血管疾病和传染病方面的应用潜力。为了解决诸如次优药代动力学、递送限制、潜在脱靶效应和工业化障碍等挑战,我们确定了需要解决的关键科学问题,并强调了新兴方向,包括人工智能设计、纳米材料递送和跨学科整合。总的来说,TPD正在推动药物开发从“功能抑制”走向“蛋白质清除”,为精准医学注入新的活力。本文旨在为后续研究和临床翻译提供系统的参考。
{"title":"Expanding the druggable proteome strategies and innovations in targeted protein degradation","authors":"Ke Ma , Ting Liu , Wen-Bo Huan, Ke-Zheng Chen, Sheng-Lin Qiao","doi":"10.1016/j.nantod.2025.102945","DOIUrl":"10.1016/j.nantod.2025.102945","url":null,"abstract":"<div><div>Targeted Protein Degradation (TPD) emerges as a novel therapeutic strategy that selectively eliminates disease-causing proteins by harnessing endogenous degradation systems, thereby overcoming the limitations of traditional drugs in addressing “undruggable” targets. This review outlines the core molecular mechanisms and primary technical platforms of TPD, including PROTACs, molecular glues (MGs), antibody-degradation conjugates, and emerging autophagy-related strategies (LYTACs, AUTACs, ATTECs, etc.). It systematically summarizes molecular engineering advances such as linker optimization, expansion of E3 ligase resources, and environmentally responsive and multi-modular designs. Furthermore, clinical and translational research cases demonstrate TPD's application potential across oncology, neurodegenerative diseases, cardiovascular disorders, and infectious diseases. Addressing challenges such as suboptimal pharmacokinetics, delivery limitations, potential off-target effects, and industrialization hurdles, we identify critical scientific questions requiring resolution and highlight emerging directions including AI-enabled design, nanomaterial delivery, and interdisciplinary integration. Overall, TPD is propelling drug development from “functional inhibition” toward “protein clearance,” injecting new vitality into precision medicine. This paper aims to provide a systematic reference for subsequent research and clinical translation.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102945"},"PeriodicalIF":10.9,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145682140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.nantod.2025.102935
Chuanyong Fan , Yao Zhou , Yihua Mei, Kaifang Wu, Meng Wang, Limeng Chen, Hongyan Liu, Zehao Dong, Lu Xu
Although metal-based antitumor agents have for long been crucial components of most chemotherapy regimens, the majority of contemporary antitumor drugs have exhibited limited tumor selectivity and considerable off-target toxicity, restricting their therapeutic efficacy. Herein, metal prodrug nanodots (CD) comprising Cu2 + and Doxorubicin (DOX) were first synthesized via coordination interaction. They were then co-loaded with Dihydroartemisinin (DHA) in a liposome nano-delivery system to enhance the metal drug’s selectivity and antitumor activity. The CD nanodots exhibited dual sensitivity to acid and Glutathione (GSH), which in turn, facilitated efficient tumor-specific drug release. Furthermore, the released Cu2+ could catalyze the endogenous H2O2 and loaded DHA, producing numerous toxic free radicals, which, in turn, induced lipid peroxidation and facilitated a synergistic antitumor effect of both Chemodynamic Therapy (CDT) and conventional chemotherapy. At the same time, Cu2+ decreased the GSH-mediated scavenging effect on the produced Reactive Oxygen Species (ROS) via a redox reaction, further enhancing the lethal effect of ROS on tumor cells. Given its potential clinical utility, this metal prodrug strategy could be leveraged for a safe and effective treatment of tumors.
{"title":"Copper-doxorubicin nanodot-based dual catalytic metal prodrug liposome for enhanced chemotherapy and Chemodynamic Combination Therapychemodynamic combination therapy","authors":"Chuanyong Fan , Yao Zhou , Yihua Mei, Kaifang Wu, Meng Wang, Limeng Chen, Hongyan Liu, Zehao Dong, Lu Xu","doi":"10.1016/j.nantod.2025.102935","DOIUrl":"10.1016/j.nantod.2025.102935","url":null,"abstract":"<div><div>Although metal-based antitumor agents have for long been crucial components of most chemotherapy regimens, the majority of contemporary antitumor drugs have exhibited limited tumor selectivity and considerable off-target toxicity, restricting their therapeutic efficacy. Herein, metal prodrug nanodots (CD) comprising Cu<sup>2 +</sup> and Doxorubicin (DOX) were first synthesized via coordination interaction. They were then co-loaded with Dihydroartemisinin (DHA) in a liposome nano-delivery system to enhance the metal drug’s selectivity and antitumor activity. The CD nanodots exhibited dual sensitivity to acid and Glutathione (GSH), which in turn, facilitated efficient tumor-specific drug release. Furthermore, the released Cu<sup>2+</sup> could catalyze the endogenous H<sub>2</sub>O<sub>2</sub> and loaded DHA, producing numerous toxic free radicals, which, in turn, induced lipid peroxidation and facilitated a synergistic antitumor effect of both Chemodynamic Therapy (CDT) and conventional chemotherapy. At the same time, Cu<sup>2+</sup> decreased the GSH-mediated scavenging effect on the produced Reactive Oxygen Species (ROS) via a redox reaction, further enhancing the lethal effect of ROS on tumor cells. Given its potential clinical utility, this metal prodrug strategy could be leveraged for a safe and effective treatment of tumors.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102935"},"PeriodicalIF":10.9,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145616639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25DOI: 10.1016/j.nantod.2025.102936
Jiayao Ding , Long Wang , Fengshuo Wang , Yue Liu , Haidong Chen , Jingchao Li , Ting Su
Nitric oxide (NO) and reactive oxygen species (ROS) are crucial signal molecules in living systems, providing alternative strategies for cancer treatment other than chemotherapy drug. Nevertheless, the uncontrollable ROS/NO induction will lead to low therapeutic results and potential off-target effects. In this paper, ROS/NO dual-releasing organic polymeric nanoenzymes (O2·-/NO-SPN) are designed, capable of synergistically elevating ROS and NO levels in tumors upon second near-infrared (NIR-II) photo-triggered activation, thus establishing a photoactivated adjuvant strategy for enhanced cancer immunotherapy. A newly synthesized semiconducting polymer (L7) with an outstanding NIR-II photothermal performance is utilized as the core for fabricating such nanoenzymes. Using a film-dispersion technique coupled with hydration, a NO donor S-nitrosoglutathione (GSNO), superoxide anions (O2·-) donor 3-indoleacetic acid (3IAA) and L7 are co-loaded in a thermal-responsive nano-liposome, followed by surface embellishment of horseradish peroxidase (HRP). The formed O2·-/NO-SPN can generate local heat via NIR-II photothermal effect, and thus the thermal-responsive nano-liposomes are collapsed to release 3IAA, which is then catalyzed by HRP to produce O2·-, triggering tumor cell death in a NIR-II photodynamic-like manner. Moreover, the local heating effect results in production of NO by GSNO to further kill tumor cells and also activate the systemic immune responses through inducing immunogenic cell death and macrophage polarization. This ROS/NO dual-releasing strategy is demonstrated to effectively inhibit bilateral tumor growths and metastasis. The current study thereby offers a promising tool to regulate both ROS and NO levels concurrently in biological systems.
{"title":"ROS/NO dual-releasing organic polymer nanoenzymes for NIR-II photo-adjuvant cancer immunotherapy","authors":"Jiayao Ding , Long Wang , Fengshuo Wang , Yue Liu , Haidong Chen , Jingchao Li , Ting Su","doi":"10.1016/j.nantod.2025.102936","DOIUrl":"10.1016/j.nantod.2025.102936","url":null,"abstract":"<div><div>Nitric oxide (NO) and reactive oxygen species (ROS) are crucial signal molecules in living systems, providing alternative strategies for cancer treatment other than chemotherapy drug. Nevertheless, the uncontrollable ROS/NO induction will lead to low therapeutic results and potential off-target effects. In this paper, ROS/NO dual-releasing organic polymeric nanoenzymes (O<sub>2</sub><sup>·-</sup>/NO-SPN) are designed, capable of synergistically elevating ROS and NO levels in tumors upon second near-infrared (NIR-II) photo-triggered activation, thus establishing a photoactivated adjuvant strategy for enhanced cancer immunotherapy. A newly synthesized semiconducting polymer (L7) with an outstanding NIR-II photothermal performance is utilized as the core for fabricating such nanoenzymes. Using a film-dispersion technique coupled with hydration, a NO donor S-nitrosoglutathione (GSNO), superoxide anions (O<sub>2</sub><sup>·-</sup>) donor 3-indoleacetic acid (3IAA) and L7 are co-loaded in a thermal-responsive nano-liposome, followed by surface embellishment of horseradish peroxidase (HRP). The formed O<sub>2</sub><sup>·-</sup>/NO-SPN can generate local heat <em>via</em> NIR-II photothermal effect, and thus the thermal-responsive nano-liposomes are collapsed to release 3IAA, which is then catalyzed by HRP to produce O<sub>2</sub><sup>·-</sup>, triggering tumor cell death in a NIR-II photodynamic-like manner. Moreover, the local heating effect results in production of NO by GSNO to further kill tumor cells and also activate the systemic immune responses through inducing immunogenic cell death and macrophage polarization. This ROS/NO dual-releasing strategy is demonstrated to effectively inhibit bilateral tumor growths and metastasis. The current study thereby offers a promising tool to regulate both ROS and NO levels concurrently in biological systems.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"67 ","pages":"Article 102936"},"PeriodicalIF":10.9,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145584253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-20DOI: 10.1016/j.nantod.2025.102933
Xiaoxue Xie , Jing Liu , Zhengjie Liu , Huiye Wei , Minzhao Lin , Gengjia Chen , Zhibo Liu , Mengyi He , Xinshuo Huang , Shuang Huang , Yunuo Wang , Ji Wang , Huijiuan Chen , Qi Chen , Xi Xie , Xintao Shuai
{"title":"Corrigendum to “Real-time ROS monitoring-guided tumor electrodynamic therapy using a metal microneedle array system” [Nano Today 63 (2025) 102731]","authors":"Xiaoxue Xie , Jing Liu , Zhengjie Liu , Huiye Wei , Minzhao Lin , Gengjia Chen , Zhibo Liu , Mengyi He , Xinshuo Huang , Shuang Huang , Yunuo Wang , Ji Wang , Huijiuan Chen , Qi Chen , Xi Xie , Xintao Shuai","doi":"10.1016/j.nantod.2025.102933","DOIUrl":"10.1016/j.nantod.2025.102933","url":null,"abstract":"","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102933"},"PeriodicalIF":10.9,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-20DOI: 10.1016/j.nantod.2025.102934
Zhenzhen Guo , Yue Qiu , Yang Wang , Jiali Zhang , Xiaotong Jiang , Danyu Wang , Hua Yi , Mengyu Huang , Peiru Chen , Fangmei Zhang , Yan Liang , Fengming Chen , Hua Gao , Qiuxia Yang , Kaixiang Zhang
The spatiotemporal profiling of membrane-localized biomarkers of cellular events is pivotal for unraveling disease pathogenesis and advancing precision medicine. However, the current inefficient multi-target discrimination, due to the limited computational capacity of monovalent logic elements and diffusion-limited signal amplification strategies, has hindered its advancement. Here, we present an innovative platform that enables integrated DNA logic gate-driven, spatially confined signal amplification at membrane interfaces. In the design, by encoding traditional monovalent DNA logic units into multivalent tandem architectures, we developed next-generation integrated DNA logic gate elements (iLGE), enabling parallel Boolean operations on multiple biomarkers with threefold enhanced computation efficiency and reduced spatial dependency. Additionally, embedding DNAzyme-mediated signal switches and substrates within a multivalent amphiphilic DNA scaffold enabled the engineering of a DNA walker device (DWD) that stably anchors to the cell membrane, facilitating a dual spatially confined signal amplification strategy. This platform possesses high sensitivity and precision in detecting localized nucleic acids, proteins, and specific cells at the engineered cell membrane interface, thereby enabling precise capture and analysis of events, including cell damage, cellular oncogenesis, and interactions between NK cells and tumor cells. It offers a new, comprehensive diagnostic and analytical platform for exploring membrane-localized events and their related disease mechanisms.
{"title":"Integrated DNA logic gate-driven cell membrane confined amplification system for imaging cellular events","authors":"Zhenzhen Guo , Yue Qiu , Yang Wang , Jiali Zhang , Xiaotong Jiang , Danyu Wang , Hua Yi , Mengyu Huang , Peiru Chen , Fangmei Zhang , Yan Liang , Fengming Chen , Hua Gao , Qiuxia Yang , Kaixiang Zhang","doi":"10.1016/j.nantod.2025.102934","DOIUrl":"10.1016/j.nantod.2025.102934","url":null,"abstract":"<div><div>The spatiotemporal profiling of membrane-localized biomarkers of cellular events is pivotal for unraveling disease pathogenesis and advancing precision medicine. However, the current inefficient multi-target discrimination, due to the limited computational capacity of monovalent logic elements and diffusion-limited signal amplification strategies, has hindered its advancement. Here, we present an innovative platform that enables integrated DNA logic gate-driven, spatially confined signal amplification at membrane interfaces. In the design, by encoding traditional monovalent DNA logic units into multivalent tandem architectures, we developed next-generation integrated DNA logic gate elements (iLGE), enabling parallel Boolean operations on multiple biomarkers with threefold enhanced computation efficiency and reduced spatial dependency. Additionally, embedding DNAzyme-mediated signal switches and substrates within a multivalent amphiphilic DNA scaffold enabled the engineering of a DNA walker device (DWD) that stably anchors to the cell membrane, facilitating a dual spatially confined signal amplification strategy. This platform possesses high sensitivity and precision in detecting localized nucleic acids, proteins, and specific cells at the engineered cell membrane interface, thereby enabling precise capture and analysis of events, including cell damage, cellular oncogenesis, and interactions between NK cells and tumor cells. It offers a new, comprehensive diagnostic and analytical platform for exploring membrane-localized events and their related disease mechanisms.</div></div>","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102934"},"PeriodicalIF":10.9,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145575973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-19DOI: 10.1016/j.nantod.2025.102928
Pengchen Wang , Jintong Na , Xiyu Liu , Minhui Cui , Ganghao Liang , Xinyue He , Haihua Xiao , Yongxiang Zhao , Yuan Liao , Liping Zhong
{"title":"Corrigendum to “Sonodynamic biodegradable pseduo-conjugate polymer delivery of warfarin for inducing generation of cancerous ROS and ferroptosis” [Nano Today 66 (2026) 102891]","authors":"Pengchen Wang , Jintong Na , Xiyu Liu , Minhui Cui , Ganghao Liang , Xinyue He , Haihua Xiao , Yongxiang Zhao , Yuan Liao , Liping Zhong","doi":"10.1016/j.nantod.2025.102928","DOIUrl":"10.1016/j.nantod.2025.102928","url":null,"abstract":"","PeriodicalId":395,"journal":{"name":"Nano Today","volume":"66 ","pages":"Article 102928"},"PeriodicalIF":10.9,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145681495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}